Key facts
- Notable investors include Antler.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for AlphaGrid
- ·The full record, as it builds
Funding rounds
No funding rounds for AlphaGrid are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AlphaGrid
Developer of an artificial intelligence-powered platform intended to transform medical imaging and diagnostics into real-time, personalized insights. The company leverages AI and digital twin technology to analyze medical imaging data, providing clinicians with real-time information to support faster and more precise treatment decisions, and it aims to aims to improve diagnostic accuracy, streamline care delivery, and enhance patient outcomes, enabling hospitals, clinics, and diagnostic centers with a range of imaging modalities and disease areas.
- Sector
- Healthcare
- HQ
- Springfield, IL, United States
- Website
- alpha-grid.ai/
- Ownership
- Privately Held (backing)
AlphaGrid doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AlphaGrid shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AlphaGrid in its N-PORT filings yet. We sweep new filings monthly.